News from cell therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 06, 2015, 06:45 ET
BrainStorm Cell Therapeutics Inc logo

BrainStorm Cell Therapeutics to Present at Cantor Fitzgerald's Inaugural Healthcare Conference

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Jun 29, 2015, 08:30 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Added to Russell Microcap® Index

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Jun 16, 2015, 09:20 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics at the BIO International Convention

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, is...

May 14, 2015, 07:05 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Announces First Quarter 2015 Financial Results and Provides Corporate Update

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

May 11, 2015, 09:04 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics to Present at Upcoming Conferences

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

May 07, 2015, 08:45 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics to Report First Quarter 2015 Financial Results on Thursday, May 14

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Apr 21, 2015, 06:55 ET
BrainStorm Cell Therapeutics

BrainStorm's NurOwn® Demonstrates a Statistically Significant Effect in ALS Patients

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, is...

Apr 14, 2015, 07:00 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics to Present Positive NurOwn® Phase 2a Clinical Data at American Academy of Neurology Annual Meeting

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Mar 26, 2015, 08:26 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Financial Results for 2014 and Provides Business Update

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Mar 19, 2015, 16:15 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics to Report Fourth Quarter and Full Year 2014 Financial Results on Thursday, March 26

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Mar 18, 2015, 09:16 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics to Present at 3rd Annual Regen Med Investor Day on March 25 in New York

 BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced...

Feb 09, 2015, 07:15 ET
BrainStorm Cell Therapeutics

BrainStorm Receives Notice of Allowance for its NurOwn™ Technology Platform from Israel's Patent Office

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Feb 04, 2015, 07:05 ET
BrainStorm Cell Therapeutics

BrainStorm CEO to Present at the 17th Annual BIO CEO & Investor Conference

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Feb 03, 2015, 08:16 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Positive DSMB Recommendation in Ongoing Phase 2 Trial with NurOwn™ in ALS

 BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Jan 26, 2015, 07:05 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Exceptional Preclinical Results of NurOwn™ in Mouse Autism Model

 BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Jan 08, 2015, 09:43 ET
BrainStorm Cell Therapeutics

BrainStorm Enters Into Warrant Exercise Agreement for Approximately $13 Million in Proceeds

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Jan 07, 2015, 08:22 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Receipt of Approximately $3.1 Million from Warrant Exercises

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Jan 06, 2015, 07:05 ET
BrainStorm Cell Therapeutics

BrainStorm CEO to Present at Two Upcoming Investor Conferences

 BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Jan 05, 2015, 08:20 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Final Analysis of Phase 2a ALS Study Showing Nearly All Subjects Experienced Clinical Benefit from NurOwn™

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Dec 22, 2014, 10:45 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics to Host Conference Call to Discuss Final Results of Phase 2a Trial of NurOwn™ in ALS on January 5, 2015

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, will...